2 research outputs found
NOTA Complexes with Copper(II) and Divalent Metal Ions: Kinetic and Thermodynamic Studies
H<sub>3</sub>nota derivatives are
among the most studied macrocyclic ligands and are widely used for
metal ion binding in biology and medicine. Despite more than 40 years
of chemical research on H<sub>3</sub>nota, the comprehensive study
of its solution chemistry has been overlooked. Thus, the coordination
behavior of H<sub>3</sub>nota with several divalent metal ions was
studied in detail with respect to its application as a chelator for
copper radioisotopes in medical imaging and therapy. In the solid-state
structure of the free ligand in zwitterionic form, one proton is bound
in the macrocyclic cavity through a strong intramolecular hydrogen-bond
system supporting the high basicity of the ring amine groups (log <i>K</i><sub>a</sub> = 13.17). The high stability of the [Cu(nota)]<sup>−</sup> complex (log <i>K</i><sub>ML</sub> = 23.33)
results in quantitative complex formation, even at pH <1.5. The
ligand is moderately selective for Cu(II) over other metal ions (e.g.,
log <i>K</i><sub>ML</sub>(Zn) = 22.32 and log <i>K</i><sub>ML</sub>(Ni) = 19.24). This ligand forms a more stable complex
with Mg(II) than with Ca(II) and forms surprisingly stable complexes
with alkali-metal ions (stability order Li(I) > Na(I) > K(I)).
Thus, H<sub>3</sub>nota shows high selectivity for small metal ions.
The [Cu(nota)]<sup>−</sup> complex is hexacoordinated at neutral
pH, and the equatorial N<sub>2</sub>O<sub>2</sub> interaction is strengthened
by complex protonation. Detailed kinetic studies showed that the Cu(II)
complex is formed quickly (millisecond time scale at <i>c</i><sub>Cu</sub> ≈ 0.1 mM) through an <i>out-of-cage</i> intermediate. Conversely, conductivity measurements revealed that
the Zn(II) complex is formed much more slowly than the Cu(II) complex.
The Cu(II) complex has medium kinetic inertness (τ<sub>1/2</sub> 46 s; pH 0, 25 °C) and is less resistant to acid-assisted decomplexation
than Cu(II) complexes with H<sub>4</sub>dota and H<sub>4</sub>teta.
Surprisingly, [Cu(nota)]<sup>−</sup> decomplexation is decelerated
in the presence of Zn(II) ions due to the formation of a stable dinuclear
complex. In conclusion, H<sub>3</sub>nota is a good carrier of copper
radionuclides because the [Cu(nota)]<sup>−</sup> complex is
predominantly formed over complexes with common impurities in radiochemical
formulations, Zn(II) and Ni(II), for thermodynamic and, primarily,
for kinetic reasons. Furthermore, the in vivo stability of the [Cu(nota)]<sup>−</sup> complex may be increased due to the formation of dinuclear
complexes when it interacts with biometals
Cyclam Derivatives with a Bis(phosphinate) or a Phosphinato–Phosphonate Pendant Arm: Ligands for Fast and Efficient Copper(II) Complexation for Nuclear Medical Applications
Cyclam
derivatives bearing one geminal bis(phosphinic acid), −CH<sub>2</sub>PO<sub>2</sub>HCH<sub>2</sub>PO<sub>2</sub>H<sub>2</sub> (H<sub>2</sub><b>L</b><sup><b>1</b></sup>), or phosphinic–phosphonic
acid, −CH<sub>2</sub>PO<sub>2</sub>HCH<sub>2</sub>PO<sub>3</sub>H<sub>2</sub> (H<sub>3</sub><b>L</b><sup><b>2</b></sup>), pendant arm were synthesized and studied as potential copper(II)
chelators for nuclear medical applications. The ligands showed good
selectivity for copper(II) over zinc(II) and nickel(II) ions (log <i>K</i><sub>CuL</sub> = 25.8 and 27.7 for H<sub>2</sub><b>L</b><sup><b>1</b></sup> and H<sub>3</sub><b>L</b><sup><b>2</b></sup>, respectively). Kinetic study revealed an unusual
three-step complex formation mechanism. The initial equilibrium step
leads to <i>out-of-cage</i> complexes with Cu<sup>2+</sup> bound by the phosphorus-containing pendant arm. These species quickly
rearrange to an <i>in-cage</i> complex with cyclam conformation <b>II</b>, which isomerizes to another <i>in-cage</i> complex
with cyclam conformation <b>I</b>. The first <i>in-cage</i> complex is quantitatively formed in seconds (pH ≈5, 25 °C,
Cu:L = 1:1, <i>c</i><sub>M</sub> ≈ 1 mM). At pH >12, <b>I</b> isomers undergo nitrogen atom inversion, leading to <b>III</b> isomers; the structure of the <b>III</b>-[Cu(H<b>L</b><sup><b>2</b></sup>)] complex in the solid state was
confirmed by X-ray diffraction analysis. In an alkaline solution,
interconversion of the <b>I</b> and <b>III</b> isomers
is mutual, leading to the same equilibrium isomeric mixture; such
behavior has been observed here for the first time for copper(II)
complexes of cyclam derivatives. Quantum-chemical calculations showed
small energetic differences between the isomeric complexes of H<sub>3</sub><b>L</b><sup><b>2</b></sup> compared with analogous
data for isomeric complexes of cyclam derivatives with one or two
methylphosphonic acid pendant arm(s). Acid-assisted dissociation proved
the kinetic inertness of the complexes. Preliminary radiolabeling
of H<sub>2</sub><b>L</b><sup><b>1</b></sup> and H<sub>3</sub><b>L</b><sup><b>2</b></sup> with <sup>64</sup>Cu was fast and efficient, even at room temperature, giving specific
activities of around 70 GBq of <sup>64</sup>Cu per 1 μmol of
the ligand (pH 6.2, 10 min, ca. 90 equiv of the ligand). These specific
activities were much higher than those of H<sub>3</sub><b>nota</b> and H<sub>4</sub><b>dota</b> complexes prepared under identical
conditions. The rare combination of simple ligand synthesis, very
fast copper(II) complex formation, high thermodynamic stability, kinetic
inertness, efficient radiolabeling, and expected low bone tissue affinity
makes such ligands suitably predisposed to serve as chelators of copper
radioisotopes in nuclear medicine